Espenida, Jysabel .
HRN: 25-42-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2024
AMPICILLIN 1GM (VIAL)
07/21/2024
07/22/2024
IV
2 Grams
Q6
PROM; THINLY MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes